Optimisation of CML therapy
TKI inhibitors have revolutionised CML therapy and the goals for management have shifted from finding newer therapies to optimising existing treatment approaches. We have tried to optimise CML therapy by identifying poor responders early by molecular monitoring, improve adherence by using self repor...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.676771 |